盐酸吡格列酮对葡萄糖调节受损的干预治疗作用  

Study of Pioglitazone Intervention Effect on Impaired Glucose Regulation

作　　者：张福英[1] 赵晓军[2] 安艳玲[3] 

机构地区：[1]太原市杏花岭区中心医院,山西太原030002 [2]山西省肿瘤医院,山西太原030013 [3]山西职工医学院,山西太原030012

出　　处：《山西职工医学院学报》2015年第1期9-11,共3页Journal of Shanxi Medical College for Continuing Education

摘　　要：目的:观察并分析盐酸吡格列酮对葡萄糖调节受损干预治疗的临床作用。方法:收集葡萄糖调节受损患者52例,随机将其分为对照组和药物干预组,每组患者各26例,两组均进行饮食控制、运动疗法,药物干预组同时给予口服盐酸吡格列酮干预调节血糖。结果:药物干预组的葡萄糖调节受损转归优于对照组,2型糖尿病的发生率明显降低,并且无明显的副作用。结论:葡萄糖调节受损的患者,在进行饮食控制、运动疗法的同时,应用盐酸吡格列酮干预调节血糖,可以使葡萄糖调节受损转归,并减少2型糖尿病的发生。Objective ： To observe and analyze the clinical effects of pioglitazone hydrochloride intervention therapy on impaired glucose regulation. Methods： 52 cases with impaired glucose regulation were randomly divided into control group and intervention group （26 cases in each group） , which were on a diet, exercise therapy with drug intervention group receiving oral pioglitazone hydrochloride intervention to regulate blood sugar. Results： The situation in drug intervention group of impaired glucose regulation prognosis was better than that in the control group. Type 2 diabetes mellitus was significantly decreased, and there were no obvious side effects. Conclusion： Impaired glucose regulation prognosis can successfully fulfilled by pioglitazone hydrochloride intervention therapy as well as diet control, exercise therapy and the incidence of type 2 diabetes mellitus can be reduced at the same time.

关 键 词：葡萄糖调节受损 糖尿病 盐酸吡格列酮 干预作用 

分 类 号：R587.1[医药卫生—内分泌]